Oncology ASCO 2024 - Steve Devine While advances in cell and gene therapies chip away at the need for bone marrow transplants, the transplantation field remains very much alive and in the midst of innovations of its own.
News Gamida Cell's cell therapy treatment gains breakthrough stat... Regulator to expedite review of blood cancer treatment
News AZ seeking $1.5bn in savings by end-2029 AstraZeneca has launched a cost-cutting programme that will aim to slash $1.5bn a year off its costs, with the savings reinvested in R&D.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.